DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Feld JJ, Moreno C, Trinh R. , et al.
Sustained virologic response of 100% in HCV genotype 1b patients with cirrhosis receiving ombitasvir/paritaprevir/r and dasabuvir for 12weeks.
J Hepatol 2016;
64 (02) 301-307
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.